Elissa Malkin

3.3k total citations
21 papers, 1.6k citations indexed

About

Elissa Malkin is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Immunology. According to data from OpenAlex, Elissa Malkin has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 8 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Elissa Malkin's work include Malaria Research and Control (12 papers), Mosquito-borne diseases and control (10 papers) and Respiratory viral infections research (6 papers). Elissa Malkin is often cited by papers focused on Malaria Research and Control (12 papers), Mosquito-borne diseases and control (10 papers) and Respiratory viral infections research (6 papers). Elissa Malkin collaborates with scholars based in United States, France and United Kingdom. Elissa Malkin's co-authors include Filip Dubovsky, Carole A. Long, Louis H. Miller, Allan Saul, Joseph F. Cortese, Malcolm E. Molyneux, Stephen J. Rogerson, Peter Winstanley, Christopher V. Plowe and Kazutoyo Miura and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Elissa Malkin

21 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elissa Malkin United States	17	1.1k	433	364	236	207	21	1.6k
Amagana Dolo Mali	26	1.3k 1.2×	186 0.4×	504 1.4×	120 0.5×	257 1.2×	67	1.8k
Magali Tichit France	14	419 0.4×	247 0.6×	321 0.9×	167 0.7×	138 0.7×	24	1.1k
Karine Kaiser France	18	1.0k 0.9×	423 1.0×	469 1.3×	250 1.1×	371 1.8×	24	1.7k
Karina Teelen Netherlands	23	1.4k 1.3×	151 0.3×	711 2.0×	212 0.9×	383 1.9×	35	1.8k
Srisin Khusmith Thailand	22	831 0.7×	241 0.6×	444 1.2×	231 1.0×	219 1.1×	68	1.3k
Ababacar Diouf United States	24	1.3k 1.2×	196 0.5×	630 1.7×	91 0.4×	412 2.0×	53	1.7k
Aïssata Ongoïba United States	22	1.3k 1.2×	172 0.4×	1.2k 3.2×	166 0.7×	218 1.1×	36	2.1k
Laura Andrews United Kingdom	17	1.0k 0.9×	173 0.4×	567 1.6×	176 0.7×	344 1.7×	20	1.5k
Oscar Kai United Kingdom	21	1.3k 1.2×	132 0.3×	674 1.9×	118 0.5×	227 1.1×	29	1.6k
Salenna R. Elliott Australia	24	1.5k 1.3×	137 0.3×	789 2.2×	87 0.4×	306 1.5×	39	1.8k

Countries citing papers authored by Elissa Malkin

Since Specialization

Citations

This map shows the geographic impact of Elissa Malkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elissa Malkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elissa Malkin more than expected).

Fields of papers citing papers by Elissa Malkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elissa Malkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elissa Malkin. The network helps show where Elissa Malkin may publish in the future.

Co-authorship network of co-authors of Elissa Malkin

This figure shows the co-authorship network connecting the top 25 collaborators of Elissa Malkin. A scholar is included among the top collaborators of Elissa Malkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elissa Malkin. Elissa Malkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Diemert, David, Maria Bova, Elissa Malkin, et al.. (2024). Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adults. PLoS neglected tropical diseases. 18(12). e0012788–e0012788. 1 indexed citations

Malkin, Elissa, Ram Yogev, Nazha Abughali, et al.. (2013). Safety and immunogenicity of a live attenuated intranasal vaccine against respiratory syncytial virus in healthy RSV seronegative children 5 to 24 months of age.. PLoS ONE. 8(10). 6 indexed citations

Malkin, Elissa, Ram Yogev, Nazha Abughali, et al.. (2013). Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age. PLoS ONE. 8(10). e77104–e77104. 58 indexed citations

Tang, Roderick S., Anu Cherukuri, Robert A. Gasser, et al.. (2013). Translational sciences approach to RSV vaccine development. Expert Review of Vaccines. 12(9). 1047–1060. 12 indexed citations

Yang, Chin‐Fen, Elissa Malkin, Jeanne H. Schickli, et al.. (2013). Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine. Vaccine. 31(26). 2822–2827. 39 indexed citations

McCarthy, James, Joanne Marjason, Suzanne Elliott, et al.. (2011). A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720. PLoS ONE. 6(9). e24413–e24413. 70 indexed citations

Bernstein, David I., Elissa Malkin, Nazha Abughali, et al.. (2011). Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children. The Pediatric Infectious Disease Journal. 31(2). 109–114. 77 indexed citations

Mallory, Raburn M., Elissa Malkin, Christopher S. Ambrose, et al.. (2010). Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials. PLoS ONE. 5(10). e13755–e13755. 48 indexed citations

Pierce, Mark A., Ruth D. Ellis, Elissa Malkin, et al.. (2010). Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults. Vaccine. 28(10). 2236–2242. 23 indexed citations

10.

Crompton, Peter D., Greta E. Weiss, Chiung‐Yu Huang, et al.. (2009). The TLR9 Ligand CpG Promotes the Acquisition of Plasmodium falciparum -Specific Memory B Cells in Malaria-Naive Individuals. The Journal of Immunology. 182(5). 3318–3326. 61 indexed citations

11.

Nwakanma, Davis, Natalia Gomez‐Escobar, Michael Walther, et al.. (2009). Quantitative Detection of Plasmodium falciparum DNA in Saliva, Blood, and Urine. The Journal of Infectious Diseases. 199(11). 1567–1574. 75 indexed citations

12.

Mullen, Gregory, Ruth D. Ellis, Kazutoyo Miura, et al.. (2008). Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria. PLoS ONE. 3(8). e2940–e2940. 85 indexed citations

13.

Huaman, Maria Cecilia, Elissa Malkin, David L. Narum, et al.. (2008). Ex Vivo Cytokine and Memory T Cell Responses to the 42-kDa Fragment of Plasmodium falciparum Merozoite Surface Protein-1 in Vaccinated Volunteers. The Journal of Immunology. 180(3). 1451–1461. 29 indexed citations

14.

Miura, Kazutoyo, Hong Zhou, Samuel E. Moretz, et al.. (2008). Comparison of Biological Activity of Human Anti-Apical Membrane Antigen-1 Antibodies Induced by Natural Infection and Vaccination. The Journal of Immunology. 181(12). 8776–8783. 48 indexed citations

15.

Malkin, Elissa, Carole A. Long, Anthony W. Stowers, et al.. (2007). Phase 1 Study of Two Merozoite Surface Protein 1 (MSP142) Vaccines for Plasmodium falciparum Malaria. PubMed. 2(4). e12–e12. 62 indexed citations

16.

Malkin, Elissa, et al.. (2006). Progress towards the development of malaria vaccines. Trends in Parasitology. 22(7). 292–295. 35 indexed citations

17.

Malkin, Elissa, David Diemert, Julie H. McArthur, et al.. (2005). Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria. Infection and Immunity. 73(6). 3677–3685. 184 indexed citations

18.

Malkin, Elissa, Anna P. Durbin, David Diemert, et al.. (2005). Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine. 23(24). 3131–3138. 191 indexed citations

19.

Malkin, Elissa, et al.. (2002). Pseudotumor cerebri secondary to minocycline intake.. PubMed. 15(3). 229–33. 19 indexed citations

20.

Kublin, James G., Fraction K. Dzinjalamala, Deborah Kamwendo, et al.. (2002). Molecular Markers for Failure of Sulfadoxine‐Pyrimethamine and Chlorproguanil‐Dapsone Treatment of Plasmodium falciparum Malaria. The Journal of Infectious Diseases. 185(3). 380–388. 421 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact